• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The changing age distribution of prostate cancer in Canada.加拿大前列腺癌患者年龄分布的变化情况。
Can J Public Health. 2007 Jan-Feb;98(1):60-4. doi: 10.1007/BF03405387.
2
Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.1981 - 2000年加拿大前列腺癌发病率、医院利用率及外科手术趋势
Can J Public Health. 2006 May-Jun;97(3):177-82. doi: 10.1007/BF03405579.
3
The impending Canadian prostate cancer epidemic.即将到来的加拿大前列腺癌流行。
Can J Public Health. 1995 Jul-Aug;86(4):274-8.
4
Prostate cancer incidence and mortality rates and trends in the United States and Canada.美国和加拿大的前列腺癌发病率、死亡率及趋势
Public Health Rep. 2004 Mar-Apr;119(2):174-86. doi: 10.1177/003335490411900211.
5
Recent trends in prostate cancer in Canada.加拿大前列腺癌的最新趋势。
Health Rep. 2019 Apr 17;30(4):12-17. doi: 10.25318/82-003-x201900400002-eng.
6
Prostate cancer trends in Canada: rising incidence or increased detection?加拿大前列腺癌的趋势:发病率上升还是检测增加?
CMAJ. 1993 Sep 1;149(5):617-24.
7
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.前列腺癌发病率、生存率、患病率和死亡率的模式与趋势。第一部分:国际比较。
BJU Int. 2002 Jul;90(2):162-73. doi: 10.1046/j.1464-410x.2002.2822.x.
8
Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015.全球、区域和国家前列腺癌负担,1990 年至 2015 年:来自 2015 年全球疾病负担研究的结果。
J Urol. 2018 May;199(5):1224-1232. doi: 10.1016/j.juro.2017.10.044. Epub 2017 Nov 9.
9
Prostate cancer incidence and mortality trends among elderly and adult Europeans.欧洲老年人和成年人前列腺癌的发病率及死亡率趋势
Crit Rev Oncol Hematol. 2000 Aug;35(2):133-44. doi: 10.1016/s1040-8428(99)00067-0.
10
Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.1971 - 1998年英格兰和威尔士前列腺癌的发病率、死亡率及生存率趋势
BJU Int. 2000 Jun;85(9):1058-62. doi: 10.1046/j.1464-410x.2000.00661.x.

引用本文的文献

1
Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.1992-2010 年加拿大前列腺癌的发病率和死亡率。
Curr Oncol. 2021 Feb 21;28(1):978-990. doi: 10.3390/curroncol28010096.
2
Global incidence of prostate cancer in developing and developed countries with changing age structures.发展中国家和发达国家中前列腺癌的全球发病率与不断变化的年龄结构。
PLoS One. 2019 Oct 24;14(10):e0221775. doi: 10.1371/journal.pone.0221775. eCollection 2019.
3
Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials.针对去势抵抗性前列腺癌老年患者的雄激素途径:随机试验的荟萃分析。
Medicine (Baltimore). 2016 Oct;95(43):e4636. doi: 10.1097/MD.0000000000004636.
4
Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.前列腺癌管理中根治性前列腺切除术手术和病理质量绩效优化指南:循证基础
Can Urol Assoc J. 2010 Feb;4(1):13-25. doi: 10.5489/cuaj.08105.

本文引用的文献

1
Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.1981 - 2000年加拿大前列腺癌发病率、医院利用率及外科手术趋势
Can J Public Health. 2006 May-Jun;97(3):177-82. doi: 10.1007/BF03405579.
2
Prostate cancer incidence and mortality rates and trends in the United States and Canada.美国和加拿大的前列腺癌发病率、死亡率及趋势
Public Health Rep. 2004 Mar-Apr;119(2):174-86. doi: 10.1177/003335490411900211.
3
Leading cancers--changes in five-year relative survival.主要癌症——五年相对生存率的变化
Health Rep. 2004 Mar;15(2):19-32.
4
Five-year relative survival from prostate, breast, colorectal and lung cancer.前列腺癌、乳腺癌、结直肠癌和肺癌的五年相对生存率。
Health Rep. 2001 Dec;13(1):23-34.
5
Prostate cancer--testing, incidence, surgery and mortality.前列腺癌——检测、发病率、手术与死亡率。
Health Rep. 2003 May;14(3):9-20.
6
Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.前列腺癌发病率和死亡率趋势:按筛查强度对死亡率变化的分析。
CMAJ. 2003 Jan 7;168(1):31-5.
7
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.一项比较早期前列腺癌根治性前列腺切除术与观察等待的随机试验。
N Engl J Med. 2002 Sep 12;347(11):781-9. doi: 10.1056/NEJMoa012794.
8
Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.模拟远处分期疾病减少对前列腺癌死亡率的影响。
Cancer. 2002 Aug 15;95(4):870-80. doi: 10.1002/cncr.10726.
9
Prevalence-corrected prostate cancer incidence rates and trends.患病率校正后的前列腺癌发病率及趋势。
Am J Epidemiol. 2002 Jan 15;155(2):148-52. doi: 10.1093/aje/155.2.148.
10
Cancer statistics, 2001.2001年癌症统计数据。
CA Cancer J Clin. 2001 Jan-Feb;51(1):15-36. doi: 10.3322/canjclin.51.1.15.

加拿大前列腺癌患者年龄分布的变化情况。

The changing age distribution of prostate cancer in Canada.

作者信息

Neutel C Ineke, Gao Ru-Nie, Blood Paul A, Gaudette Leslie A

机构信息

Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada, Ottawa, ON.

出版信息

Can J Public Health. 2007 Jan-Feb;98(1):60-4. doi: 10.1007/BF03405387.

DOI:10.1007/BF03405387
PMID:17278680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6976190/
Abstract

BACKGROUND

Prostate cancer incidence rates are still increasing steadily; mortality rates are levelling, possibly decreasing; and hospitalization rates for many diagnoses are decreasing. Our objective is to examine changes in age distributions of prostate cancer during these times of change.

METHODS

Prostate cancer cases were derived from the Canadian Cancer Registry, prostate cancer deaths from Vital Statistics, hospitalizations from the Hospital Morbidity File. Age-standardized rates were calculated based on the 1991 Canadian population. A prevalence correction for incidence rates was calculated.

RESULTS

Age-specific incidence rates increased until 1995 for all ages, but a superimposed peak (1991-94) was greatest between ages 60-79. After 1995, increases in incidence continued for the under-70 age groups. Prevalence correction indicated the greatest underestimation of incidence rates for the oldest ages, but was less in Canada than in the United States. Mortality rates increased until 1994, then levelled and slowly decreased; age-specific mortality rates showed the greatest increase for the oldest ages but the earliest downturn for younger age groups. While hospitalizations dropped drastically after 1991, this drop was confined to elderly men (70+).

CONCLUSIONS

Dramatic changes in age distributions of prostate cancer incidence, mortality and hospitalizations altered age profiles of men with prostate cancer. This illustrated the changing nature of prostate cancer as a public health issue and has important implications for health care provision, e.g., the increased numbers of younger new patients have different needs from the increasing numbers of elderly long-term patients who now spend less time in hospital.

摘要

背景

前列腺癌发病率仍在稳步上升;死亡率趋于平稳,甚至可能下降;许多诊断的住院率正在下降。我们的目的是研究在这些变化时期前列腺癌年龄分布的变化情况。

方法

前列腺癌病例来自加拿大癌症登记处,前列腺癌死亡数据来自人口动态统计,住院数据来自医院发病率档案。基于1991年加拿大人口计算年龄标准化率。计算发病率的患病率校正值。

结果

各年龄段的年龄别发病率在1995年前均有所上升,但叠加峰值(1991 - 1994年)在60 - 79岁之间最为明显。1995年后,70岁以下年龄组的发病率持续上升。患病率校正表明,年龄最大组的发病率被低估得最多,但在加拿大比在美国程度要轻。死亡率在1994年前上升,然后趋于平稳并缓慢下降;年龄别死亡率在年龄最大组上升幅度最大,但在较年轻年龄组下降最早。虽然1991年后住院率大幅下降,但这种下降仅限于老年男性(70岁及以上)。

结论

前列腺癌发病率、死亡率和住院率的年龄分布发生了显著变化,改变了前列腺癌患者的年龄构成。这说明了前列腺癌作为一个公共卫生问题的性质正在发生变化,并且对医疗保健服务具有重要意义,例如,越来越多的年轻新患者有不同的需求,与越来越多的老年长期患者不同,后者现在住院时间减少。